Analysis of CBP (CREBBP) gene deletions in Rubinstein‐Taybi syndrome patients using real‐time quantitative PCR
暂无分享,去创建一个
D. Lacombe | L. Monnet | L. Taine | B. Arveiler | Didier Lacombe | Isabelle Coupry | Benoît Arveiler | Laurence Monnet | Azza Abd El Moneim Attia | Laurence Taine | I. Coupry | Azza Abd El Moneim Attia
[1] C. Cruaud,et al. Molecular analysis of the CBP gene in 60 patients with Rubinstein-Taybi syndrome , 2002, Journal of medical genetics.
[2] J. Morton,et al. Fragile X syndrome is less common than previously estimated. , 1997, Journal of medical genetics.
[3] Á. Carracedo,et al. Rapid real-time fluorescent PCR gene dosage test for the diagnosis of DNA duplications and deletions. , 2000, Clinical chemistry.
[4] A. Lang,et al. The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. , 2001, Human molecular genetics.
[5] N. Tommerup,et al. Tentative assignment of a locus for Rubinstein-Taybi syndrome to 16p13.3 by a de novo reciprocal translocation, t(7;16)(q34;p13.3). , 1992, American journal of medical genetics.
[6] L. Gaunt,et al. Rubinstein-Taybi syndrome with deletions of FISH probe RT1 at 16p13.3: two UK patients. , 1996, Journal of medical genetics.
[7] Y. Makita,et al. Submicroscopic deletion of chromosome region 16p13.3 in a Japanese patient with Rubinstein-Taybi syndrome. , 1994, American journal of medical genetics.
[8] R. Hennekam,et al. Rubinstein-Taybi syndrome caused by a De Novo reciprocal translocation t(2;16)(q36.3;p13.3). , 2000, American journal of medical genetics.
[9] Y. Kuroki,et al. Rubinstein-Taybi syndrome with de novo reciprocal translocation t(2;16)(p13.3;p13.3). , 1991, American journal of medical genetics.
[10] E. Mariman,et al. Deletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspects. , 1993, American journal of human genetics.
[11] D. Lacombe,et al. Confirmation of assignment of a locus for Rubinstein-Taybi syndrome gene to 16p13.3. , 1992, American journal of medical genetics.
[12] G. Nicholson,et al. Determination of gene dosage at the PMP22 and androgen receptor loci by quantitative PCR. , 1998, Clinical chemistry.
[13] Masatoshi Hagiwara,et al. Phosphorylated CREB binds specifically to the nuclear protein CBP , 1993, Nature.
[14] M. Breuning,et al. Conjunction dysfunction: CBP/p300 in human disease. , 1998, Trends in genetics : TIG.
[15] D. Lacombe,et al. Submicroscopic deletion of chromosome 16p13.3 in patients with Rubinstein-Taybi syndrome. , 1998, American journal of medical genetics.
[16] T. Wienker,et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. , 2002, American journal of human genetics.
[17] S. Ring,et al. Comparative multiplex dosage analysis detects whole exon deletions at the phenylalanine hydroxylase locus , 2003, Human mutation.
[18] L. Deaven,et al. Construction of a 1.2-Mb contig surrounding, and molecular analysis of, the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3. , 1997, Genomics.
[19] Raoul C. M. Hennekam,et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP , 1995, Nature.
[20] R. Hennekam,et al. Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations , 2000, Journal of medical genetics.
[21] E. Ringelstein,et al. PCR-based strategy for the diagnosis of hereditary neuropathy with liability to pressure palsies and Charcot-Marie-Tooth disease type 1A , 1998, Neurology.
[22] L. Jackson,et al. Submicroscopic deletions at 16p13.3 in Rubinstein-Taybi syndrome: frequency and clinical manifestations in a North American population. , 1997, Journal of medical genetics.
[23] Dominique Stoppa-Lyonnet,et al. Rapid detection of novel BRCA1 rearrangements in high‐risk breast‐ovarian cancer families using multiplex PCR of short fluorescent fragments , 2002, Human mutation.
[24] Johan T den Dunnen,et al. Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization. , 2002, American journal of human genetics.
[25] H. Saal,et al. Variation in microdeletions of the cyclic AMP-responsive element-binding protein gene at chromosome band 16p13.3 in the Rubinstein-Taybi syndrome. , 2000, American journal of medical genetics.